Pidolic Acid

Pidolic Acid

SCHEMBL5329611

CC(=O)O[C@@H](C)C(=O)O.O=C1CC[C@@H](C(=O)O)N1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Pidolic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.35
LMNA P02545 1/20 0.34
CNR1 P21554 1/20 0.33
DAGLA Q9Y4D2 1/20 0.33
GAA P10253 1/20 0.33
CAD P27708 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 1/20 0.31
HCRTR2 O43614 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8749152 0.83 LMNA (0.42) POLBLMNACNR1DAGLAGAA
SCHEMBL8749155 0.83 LMNA (0.42) POLBLMNACNR1DAGLAGAA
Pidolic Acid SCHEMBL28255303 0.81 CAD (0.40) POLBLMNACNR1DAGLAGAA
Pidolic Acid SCHEMBL1239532 0.79 CAD (0.46) POLBLMNAGAACADSMN1; SMN2
Pidolic Acid SCHEMBL15791 0.79
Pidolic Acid SCHEMBL29479230 0.79
Pidolic Acid SCHEMBL152441 0.79 CAD (0.46) POLBLMNAGAACADSMN1; SMN2
Pidolic Acid SCHEMBL7554345 0.79 CAD (0.46) POLBLMNAGAACADSMN1; SMN2
Pidolic Acid SCHEMBL10937920 0.79 CAD (0.46) POLBLMNAGAACADSMN1; SMN2
Pidolic Acid SCHEMBL15790 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007136323-A1 A NOVEL PROCESS SUITABLE FOR LARGE-SCALE PRODUCTION OF PHENYL PROPAN DERIVATIVES OF FORMULA I ALBIREO AB (SE) 2007-11-29 WO claimed
US-20070270487-A1 Novel process and intermediates 085 ASTRAZENECA AB (SE) 2007-11-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270487-A1 Novel process and intermediates 085 CYP3A5, AGPAT5, CYP4F8 POLB 1178/4885LMNA 3669/4885CNR1 2430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.